Article
Chronic Myeloid Leukemia Stem Cell Biology
30 Mar 2012
Abstract excerpt
Leukemia progression and relapse is fueled by leukemia stem cells (LSC) that are resistant to current treatments. In the progression of chronic myeloid leukemia (CML), blast crisis progenitors are capable of adopting more primitive but deregulated stem cell features with acquired resistance to targeted therapies. This in turn promotes LSC behavior characterized by aberrant self-renewal, differentiation, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
